GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
HealthCare Global Enterprises Ltd

HealthCare Global Q2 FY27 Standalone Revenue Rises to Rs. 39,604 Lakhs

RESULTS ▼ Concern Flagged MEDIUM RISK
📅 Filed on BSE: 05 Nov 2026, 08:08 PM IST  ·  BSE ID: 74edb23f-e198-4832-bf6a-4a51125269e6
View Original BSE Filing (PDF)
💡
In Simple Terms
HealthCare Global reported its latest financial results, showing an increase in revenue but a loss before tax due to special charges.
🤖 AI Summary
  • HealthCare Global's Q2 FY27 standalone revenue from operations was Rs. 39,604 Lakhs, up from Rs. 34,441 Lakhs YoY.
  • Profit before tax for Q2 FY27 stood at Rs. (293) Lakhs, following exceptional items of Rs. (661) Lakhs.
  • Total expenses for the quarter ended September 30, 2026, were Rs. 39,767 Lakhs.
  • For the six months ended September 30, 2026, standalone revenue from operations was Rs. 77,129 Lakhs.
  • Net cash generated from operating activities for the six-month period was Rs. 3,558 Lakhs.
🔢 Key Numbers - exact figures from BSE filing, not rounded
Revenue from operations (Q2 FY27)
Rs. 39,604 Lakhs
15.00%
Profit/(loss) for the period (Q2 FY27)
Rs. (204) Lakhs
Exceptional items (Q2 FY27)
Rs. (661) Lakhs
Total expenses (Q2 FY27)
Rs. 39,767 Lakhs
18.68%
Revenue from operations (H1 FY27)
Rs. 77,129 Lakhs
15.06%
🏢 How This Affects the Company
📈
Business Impact
The increase in revenue from operations to Rs. 39,604 Lakhs for Q2 FY27 indicates continued business activity growth for the standalone entity.
💰
Financial Impact
The reported loss before tax of Rs. (293) Lakhs for Q2 FY27, primarily influenced by exceptional items of Rs. (661) Lakhs, impacts quarterly profitability metrics. Cash and cash equivalents decreased from Rs. 47,411 Lakhs at March 31, 2026, to Rs. 3,167 Lakhs at September 30, 2026.
⚙️
Operational Impact
Employee benefits expense increased to Rs. 7,007 Lakhs in Q2 FY27 from Rs. 5,286 Lakhs in Q2 FY26, suggesting expansion in the workforce or remuneration. Medical consultancy charges also rose to Rs. 8,083 Lakhs, indicating higher service utilization.
⚠️
Risk Impact
The recognition of exceptional items amounting to Rs. (661) Lakhs in Q2 FY27 introduces a one-time financial adjustment that impacts reported profit.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required by shareholders based on this financial results filing.
👤
Who Is Affected
Shareholders are affected by the reported standalone loss of Rs. (204) Lakhs for Q2 FY27, impacting basic earnings per share, which was Rs. (0.14) for the quarter.
🔍
Management Signal
The Board's approval of the unaudited financial results for the quarter and six months ended September 30, 2026, indicates adherence to regulatory disclosure requirements.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Q3 FY27 results — monitor revenue growth and impact of exceptional items.
Analysis of Consolidated Financial Results, typically filed alongside standalone.
Management commentary on capital expenditure and investment plans.
MEDIUM RISK The standalone loss for the period, driven by significant exceptional items, presents a financial concern.
💡 Investor Takeaway
HealthCare Global's standalone revenue from operations for Q2 FY27 increased to Rs. 39,604 Lakhs, a 15.00% YoY rise. However, the company reported a loss of Rs. (204) Lakhs for the period, primarily due to Rs. (661) Lakhs in exceptional items.
⚖️ Strengths & Concerns

✅ Positives

  • Revenue from operations increased by 15.00% to Rs. 39,604 Lakhs in Q2 FY27 from Rs. 34,441 Lakhs in Q2 FY26.
  • Six-month revenue from operations grew by 15.06% to Rs. 77,129 Lakhs for H1 FY27 from Rs. 67,034 Lakhs for H1 FY26.

⚠️ Concerns

  • The company reported a loss for the period of Rs. (204) Lakhs in Q2 FY27, compared to a profit of Rs. 1,078 Lakhs in Q2 FY26.
  • Exceptional items of Rs. (661) Lakhs significantly impacted profit before tax, which stood at Rs. (293) Lakhs in Q2 FY27.
📅 Company Track Record
Previous filings for HealthCare Global show Q2 FY27 consolidated revenue rose 15.8% to INR 7,318 Mn, and Adjusted EBITDA increased 17.2%. The Q1 FY27 Adjusted PAT was up 190% YoY to INR 138 Million.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
What was HealthCare Global's standalone revenue from operations in Q2 FY27?
HealthCare Global's standalone revenue from operations for the quarter ended September 30, 2026 (Q2 FY27) was Rs. 39,604 Lakhs.
What was HealthCare Global's profit or loss for Q2 FY27?
HealthCare Global reported a standalone loss for the period of Rs. (204) Lakhs for the quarter ended September 30, 2026 (Q2 FY27).
What were the exceptional items reported by HealthCare Global in Q2 FY27?
HealthCare Global reported exceptional items of Rs. (661) Lakhs for the quarter ended September 30, 2026 (Q2 FY27).
What were HealthCare Global's total expenses for Q2 FY27?
HealthCare Global's total standalone expenses for the quarter ended September 30, 2026 (Q2 FY27) were Rs. 39,767 Lakhs.
What was HealthCare Global's basic earnings per share for Q2 FY27?
HealthCare Global's basic earnings per equity share (face value of Rs. 10 each) for Q2 FY27 was Rs. (0.14).

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.